AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
In this episode of the Global Medical Device Podcast, host Etienne Nichols welcomes back Dr. Mike Drues to discuss the critical aspects of obtaining Institutional Review Board (IRB) approval and interacting with the FDA for medical device clinical trials. They explore the roles of IRBs, the difference between significant and non-significant risk devices, and share invaluable advice on mitigating risks associated with clinical trials. Whether you're a newcomer or a seasoned professional in the MedTech industry, this episode offers essential insights to ensure your clinical studies are compliant and efficient.
An Institutional Review Board (IRB) is a committee established to review and approve research involving human subjects. The primary purpose of an IRB is to ensure the ethical and safe treatment of participants in clinical trials.
An Investigational Device Exemption (IDE) allows a medical device to be used in a clinical study to collect safety and effectiveness data. An IDE must be approved by the FDA for significant risk devices before a clinical study can begin.
We'd love your feedback on this episode! Please leave us a review on iTunes and share your suggestions for future topics. Email us at podcast@greenlight.guru
Revolutionize your clinical study process with Greenlight Guru’s state-of-the-art electronic data capture (EDC) system, designed specifically for the medical device industry. Streamline your clinical data management, ensure compliance, and make informed decisions with real-time insights. Visit Greenlight Guru today to learn more and take advantage of our special offers for podcast listeners.